OncoCyte (NASDAQ:OCX) Stock, Quote.Headers.trade-ideas

OncoCyte

OncoCyte Corporation Common Stock

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ADIL

AEYE

Alterity Therapeutics Limited - American Depositary Shares

ATHE

BHVN

BTCY

CENX

CMAX

Envoy Medical, Inc. - Class A Common Stock

COCH

DXYZ

EGIO

EXTR

HUBC

IMCC

INFA

KAVL

KUKE

LGVN

LOCL

MNDR

MRNS

NMRA

Nuveen California Dividend Advantage Municipal Fund 2

NXPL

ONVO

PROK

PSNY

QTTB

RARE

RENT

SNGX

SNPO

SPCB

SPWR

SRFM

SWVL

TCON

VERU

VIAO

WIRE

Shares of  Ultragenyx Pharmaceutical Inc.  (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Pre-Market Outlook

ALLR

BPTS

MARPS

SINT

Shares of  Medical Properties Trust, Inc. (NYSE: MPW) rose sharply in today’s pre-market trading after the company announced that it sold its majority interest in Utah Hospitals.

Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

Short Ideas

CRIS

RVMD

As of April 12, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Top 3 Health Care Stocks That May Collapse In Q2

OncoCyte Corp

JMP Securities analyst Nicholas Jones reiterates Xometry (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XMTR#NASDAQ">XMTR</a>) with a Market Outperform and maintains $27 price target.

Price Target

Reiteration

Analyst Ratings

XMTR

JMP Securities Reiterates Market Outperform on Xometry, Maintains $27 Price Target

Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) announced a generative AI-powered personal assistant, codenamed Project Amelia, available in beta starting Thursday for an <a href="https://www.aboutamazon.com/news/innovation-at-amazon/amazon-project-amelia">initial set of U.S. sellers.</a>
The Details: Amazon said Project Amelia provides an all-in-one, generative AI-based "selling expert" available from any page within Seller Central. Sellers can ask Amelia knowledge-based questions to receive personalized answers based on Amazon's best practices. Amelia can also provide sellers with status updates, metrics and sales and traffic data.  
Read Next: <a href="https://www.benzinga.com/fintech/24/09/40928342/what-happened-with-sofi-stock-today">What Happened With SoFi Stock Today?</a>
Amazon said Amelia will soon be able to offer resolution paths to issues and tasks by diagnosing problems and, in some cases, offering to take action on behalf of sellers. Amazon will continue to enhance the core knowledgebase for Project Amelia and build on its features and capabilities.&nbsp;
"As Amelia evolves, it will provide a more personalized experience and will increasingly gain the ability to not only converse with sellers, but anticipate their needs, take actions, and resolve issues on their behalf," Amazon said in a blog post.&nbsp;
Project Amelia was developed using the Amazon Bedrock managed service for building generative AI applications and is available in beta Thursday to an initial set of U.S. sellers. Project Amelia will progressively roll out to additional U.S. sellers in the coming weeks and will begin a phased rollout in additional countries later this year.&nbsp;
AMZN Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Amazon shares are up 1.5% at $189.24 at the time of publication Thursday.&nbsp;
Read Also:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40923038/whats-going-on-with-carnival-stock">What&#8217;s Going On With Carnival Stock?</a></li>
</ul>
Image: Unsplash

Large Cap

AMZN

Amazon Launches AI Assistant Codenamed 'Project Amelia'

WIIM

STLD

Shares of steel stocks are trading higher amid a rise in the metal's price after the Fed cut rates by 50 basis points at the FOMC yesterday. On September 13, Senator Casey announced that the United States Trade Representative finalized an increase on Section 301 tariffs.

As Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) becomes a key <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40927528/microstrategy-raises-875m-in-convertible-notes-plans-further-bitcoin-purchases">asset for corporate treasuries</a>, public companies are increasingly adopting innovative strategies to maximize their Bitcoin holdings.
What Happened: What began with MicroStrategy's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) decision to include Bitcoin in its corporate treasury has sparked a wave of similar moves by companies like Cathedra Bitcoin (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBTTF#OTC">CBTTF</a>), Metaplanet and Semler Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMLR#NASDAQ">SMLR</a>).
The trend is redefining how firms manage their balance sheets and navigate economic uncertainty, <a href="https://www.coindesk.com/business/2024/09/19/maximizing-bitcoin-per-share-a-new-corporate-strategy/?utm_medium=referral&amp;utm_source=rss&amp;utm_campaign=headlines">according</a> to Coindesk.
MicroStrategy, led by Michael Saylor, stands at the forefront of this shift, recently expanding its Bitcoin portfolio to 244,800 coins, valued at nearly $9.45 billion. Saylor's approach, positioning Bitcoin as a hedge against inflation, has sent MicroStrategy's stock soaring—up 295% over the past year. 
The company's continued investments in Bitcoin, including a recent $700 million bond offering to finance more acquisitions, signal a long-term commitment to the cryptocurrency. 
Despite concerns over the stock's mixed technical outlook, Saylor remains bullish, stating that Bitcoin's role in corporate finance will only grow.
MicroStrategy's strategy has paved the way for other companies to follow suit. 
Cathedra Bitcoin, a publicly traded firm on the TSX Venture Exchange, has shifted its focus from Bitcoin mining to managing data centers, aiming to increase its Bitcoin holdings per share. 
As mining becomes more challenging due to Bitcoin halving, Cathedra's new approach allows it to generate sustainable cash flow while continuously acquiring more Bitcoin. 
"Going forward, we will make all capital allocation decisions with the intention of maximizing our shareholders' per-share Bitcoin holdings," the company said in a recent statement.
Metaplanet has taken a similar approach, focusing on growing its Bitcoin reserves month over month. 
The company's strategy has led to a 587% increase in its stock value this year, underscoring the market's positive response to this trend. 
CEO Simon Gerovich emphasized that prioritizing Bitcoin holdings has been a key driver of the company's recent success.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/27091545/Benzinga-conference.gif" alt="Benzinga future of digital assets conference" class="wp-image-267246" /></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40937057/bitcoin-ethereum-etfs-see-over-50m-net-outflows-despite-feds-50-bps-rate-cut">Bitcoin, Ethereum ETFs See Over $50M Net Outflows Despite Fed&#8217;s 50 Bps Rate Cut</a>
Why It Matters: These moves reflect a broader shift toward using Bitcoin not only as a hedge against inflation but as a strategic asset to enhance shareholder value.
Companies like MicroStrategy and Cathedra are now leading the charge in what has been described as the <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40776328/microstrategys-bitcoin-strategy-has-outperformed-every-s-p-500-company-and-even-nvidia-sin">"maximize Bitcoin per share" strategy</a>.
This approach focuses on increasing Bitcoin reserves over time, leveraging the cryptocurrency's long-term growth potential.
MicroStrategy has further diversified its strategy by offering convertible bonds backed by Bitcoin collateral. 
These financial instruments, which offer a 1% interest rate, have attracted investors seeking lower-risk exposure to Bitcoin. 
"We're capturing a 50% premium or 50% type BTC yield on that up front," Saylor said, explaining how the bonds allow the company to acquire more Bitcoin while minimizing volatility.
The success of MicroStrategy's strategy has been hard to ignore. 
Since the company adopted Bitcoin in 2020, it has outperformed every company in the S&amp;P 500, achieving an average annual return of 44%. 
Saylor highlighted that even Nvidia, the index's top-performing stock, has been outpaced by MicroStrategy's Bitcoin-focused approach.
However, the strategy is not without risks. 
With mixed technical signals, including a bearish Moving Average Convergence Divergence (MACD) and a neutral Relative Strength Index (RSI), MicroStrategy's stock could face near-term volatility. 
The company's long-term success will depend on the broader adoption of Bitcoin and the potential for Bitcoin ETFs, which could bring the cryptocurrency <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40899629/microstrategy-doubles-down-on-bitcoin-can-the-stock-sustain-its-rally">further into the financial mainstream.</a>
As Bitcoin continues to reshape corporate strategies, these developments will be a focal point at Benzinga's <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> event on Nov. 19.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40927528/microstrategy-raises-875m-in-convertible-notes-plans-further-bitcoin-purchases">MicroStrategy Raises $875M In Convertible Notes, Plans Further Bitcoin Purchases</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

CBTTF

MSTR

SMLR

MicroStrategy's Bitcoin Playbook Is Becoming A Hit Among Companies, But There's A Catch

JMP Securities analyst Mitch Germain reiterates Whitestone REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSR#NYSE">WSR</a>) with a Market Outperform and maintains $15 price target.

JMP Securities Reiterates Market Outperform on Whitestone REIT, Maintains $15 Price Target

JP Morgan analyst Anne Samuel maintains Progyny (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGNY#NASDAQ">PGNY</a>) with a Overweight and lowers the price target from $31 to $22.

PGNY

JP Morgan Maintains Overweight on Progyny, Lowers Price Target to $22

Bank of America Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) shares are trading higher by 2.57% to $40.64 Thursday morning. Major indexes and several <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40937291/bank-stocks-hit-inflection-point-after-feds-50-basis-point-cut-analyst-reveal-top-p">bank stocks</a> are higher after the Federal Reserve cut interest rates by 50 basis points.
Why This Matters: Bank of America, like other large banks, generates a significant portion of its income through its net interest margin, which is the difference between the interest it earns on loans and the interest it pays on deposits. 
While a rate cut might initially lower the income from loans, lower rates can stimulate borrowing, potentially increasing loan demand. BofA could capitalize on this with higher volumes of loans, boosting overall interest income despite the lower rates.
As a major lender, BofA stands to benefit from increased loan origination, particularly in mortgage lending, personal loans and corporate financing. This could improve the company&#8217;s loan portfolio and revenue streams.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40938732/wall-street-ramps-up-interest-rate-cut-bets-after-fed-meeting-the-hard-landing-crow">Wall Street Ramps Up Interest Rate Cut Bets After Fed Meeting: &#8216;The Hard-Landing Crowd Should Disperse,&#8217; Economist Says</a>
What Else: With rate cuts, consumers may also be more inclined to refinance existing debt or take on new debt at favorable rates. BofA could see increased activity in its consumer banking division, including mortgages, auto loans and credit cards. 
Increased consumer spending could also drive higher transaction volumes, which would benefit its wealth management and transaction services divisions. 
Read Also: <a href="https://www.benzinga.com/news/large-cap/24/09/40938804/gamestop-ceo-ryan-cohen-penalized-nearly-1m-over-wells-fargo-share-acquisition">GameStop CEO Ryan Cohen Penalized Nearly $1M Over Wells Fargo Share Acquisition</a>
<h2 class="wp-block-heading">How To Buy BAC Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Bank of America&#8217;s case, it is in the Financials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, BAC has a 52-week high of $44.44 and a 52-week low of $24.96.

What's Going On With Bank Of America (BAC) Shares

JP Morgan analyst John Royall maintains World Kinect (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WKC#NYSE">WKC</a>) with a Neutral and raises the price target from $29 to $32.

JP Morgan Maintains Neutral on World Kinect, Raises Price Target to $32

JMP Securities analyst Patrick Walravens reiterates Workday (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>) with a Market Outperform and maintains $315 price target.

WDAY

JMP Securities Reiterates Market Outperform on Workday, Maintains $315 Price Target

- Reuters Citing Israeli Military Statement&nbsp;

Macro Notification

General

iShares MSCI Israel Capped Investable Market Index Fund

ISRA

Two Israeli Soldiers Killed Near Lebanon Border

JP Morgan analyst Tami Zakaria maintains Trimble (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRMB#NASDAQ">TRMB</a>) with a Neutral and raises the price target from $58 to $66.

TRMB

JP Morgan Maintains Neutral on Trimble, Raises Price Target to $66

JMP Securities analyst Chris Muller reiterates BrightSpire Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRSP#NYSE">BRSP</a>) with a Market Outperform and maintains $7.5 price target.

BRSP

JMP Securities Reiterates Market Outperform on BrightSpire Capital, Maintains $7.5 Price Target

Associated Capital Group Shares Halted On Code News Pending

Associated Capital Group, Inc. ("AC" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AC#NYSE">AC</a>), today announced that its Board of Directors has declared a special cash dividend of $2.00 per share, payable on November 4, 2024, to Class A and Class B shareholders of record as of the close of business on October 21, 2024. The aggregate payment will be approximately $42.4 million, based on shares outstanding of 21.2 million as of the date of this release. &nbsp;
Since its inception as a public company in 2015 and including the current estimated special dividend, AC has returned approximately $81.1 million to shareholders through dividends.

Dividends

Associated Capital Group Announces Special Dividend Of $2 Per Share, Payable On November 4, 2024, To Class A And Class B Shareholders Of Record As Of The Close Of Business On October 21, 2024

Rezolve AI Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RZLV#NASDAQ">RZLV</a>) shares are trading higher on Thursday after the company commended Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) and BlackRock, Inc.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/g40937058/rezolve-ai-welcomes-microsoft-and-blackrocks-30-billion-investment-in-ai-infrastructure-as-a-game-" rel="noreferrer noopener">$30 billion investment in AI infrastructure</a>.
Earlier this week, Microsoft partnered with investment company&nbsp;BlackRock&nbsp;and several other partners on a new&nbsp;$30 billion&nbsp;investment fund to target the growing&nbsp;<a target="_blank" href="https://www.benzinga.com/topic/artificial-intelligence" rel="noreferrer noopener">artificial intelligence sector.</a>
The new investment, which adds to Microsoft&#8217;s&nbsp;<a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/23/01/30527688/microsoft-ramps-efforts-to-build-ai-supercomputer-with-chatgpt-ahead-of-q2-earnings" rel="noreferrer noopener">growing bets on the AI space</a>, includes the participation of BlackRock,&nbsp;Global Infrastructure Partners&nbsp;and&nbsp;MGX.
Related: <a target="_blank" href="https://www.benzinga.com//node/40909973" rel="noreferrer noopener">BlackRock, Microsoft, Others Team Up For $30B Artificial Intelligence Fund: Help US Fuel &#8216;AI Innovation And Economic Growth&#8217;</a>
Rezolve AI said it is set to capitalize on the AI infrastructure upgrade, enhancing its proprietary solutions like the Brain Suite, driven by the brainpowa LLM, to advance hyper-personalization in commerce and customer engagement.
The investment by Microsoft and BlackRock underscores AI&#8217;s transformative potential on a large scale, positioning Rezolve AI to lead this evolution in the commerce sector.
Daniel M. Wagner, CEO of Rezolve AI, said, &#8220;The substantial investment by Microsoft and BlackRock into AI infrastructure reflects the accelerating pace of AI adoption across every industry.&#8221;
&#8220;For companies like Rezolve AI, this investment marks a pivotal shift in the landscape, providing the technological foundation that will allow AI innovators to scale more rapidly and deliver increasingly sophisticated solutions.&#8221;
&#8220;As a company committed to revolutionizing commerce through our suite of AI products, including Brain Commerce and Brain Checkout, we view this as a tremendous opportunity to leverage the evolving infrastructure and collaborate with major players in AI.&#8221;
Also, Rezolve AI responded to OpenAI&#8217;s new release, &#8220;Strawberry.&#8221; CEO Daniel M. Wagner emphasized his conviction that the future of AI lies in industry-specific<a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/g40901998/rezolve-ai-joins-openais-latest-release-advocates-for-vertical-market-ai-solutions-in-retail-and-c" rel="noreferrer noopener"> solutions tailored to vertical markets</a>.
Price Action: RZLV shares are up 41.7% at $6.73 at the last check Thursday.
Image via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/40940207" target="_blank" rel="noreferrer noopener">Plug Power Fuels Sales Boom With $150M+ Equipment Leasing Strategy &#8211; What&#8217;s The Benefit?</a></li>
</ul>

Equities

MSFT

RZLV

Rezolve AI Set To Ride The AI Wave - What's Going On?

JP Morgan analyst Andrea Teixeira maintains Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) with a Overweight and raises the price target from $179 to $186.

JP Morgan Maintains Overweight on Procter & Gamble, Raises Price Target to $186

Stephens &amp; Co. analyst Scott Fidel reiterates Ardent Health Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARDT#NYSE">ARDT</a>) with a Overweight and maintains $24 price target.

ARDT

Stephens & Co. Reiterates Overweight on Ardent Health Partners, Maintains $24 Price Target

The process behind top-shelf cheeses, aged meats, reserved wines and premium cannabis all relies on one thing: precise control of time, temperature and moisture. Whether aging cheddar or curing cannabis, the science of preservation unlocks quality. 
Nested in Vermont, Cannatrol is a family-owned venture that applies these same principles to cannabis drying, boosting growers&#8217; profits by reducing labor, product loss and inefficiencies. By minimizing touch points and preserving valuable terpenes, the system helps growers maintain potency and quality, ensuring profits don't evaporate in postharvest handling.
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can&#8217;t afford to miss out if you're serious about the business.</li>
</ul>
<h2 class="wp-block-heading">The Problem, The Solution And The Market Need</h2>
Founded by Jane and David Sandelman, Cannatrol is transforming postharvest cannabis processing with its innovative drying and curing technology.
David, an inventor with a background in energy and temperature controls, saw a common problem facing cheesemakers: the difficulty of achieving precise aging conditions without access to traditional cheese caves.&nbsp;
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="894" height="1024" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/18190019/Bethany-Farm-New-Logo-1-894x1024.jpg" alt="" class="wp-image-555103" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/18190019/Bethany-Farm-New-Logo-1-894x1024.jpg 894w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/18190019/Bethany-Farm-New-Logo-1-262x300.jpg 262w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/18190019/Bethany-Farm-New-Logo-1-768x880.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/18190019/Bethany-Farm-New-Logo-1.jpg 943w" sizes="(max-width: 894px) 100vw, 894px" /><figcaption class="wp-element-caption">Courtesy of Cannatrol</figcaption></figure>
Using his experience in temperature control, David developed a method to manage vapor pressure in these environments. When cannabis began its path toward legalization, it became clear that this same technology could be adapted for drying and curing cannabis flowers.
"The physics of drying cheese and cannabis are remarkably similar," David explained. "Both require precise moisture and temperature control to preserve quality, whether you're producing a fine cheese or top-shelf cannabis."&nbsp;
Unlike conventional drying methods that rely on air conditioners and dehumidifiers, Cannatrol ensures there are no fluctuating temperatures and moisture levels are stable throughout the process, drying evenly and consistently. 
"Minimal variations in airflow, temperature and humidity can damage the glands that cover the flower. These glands known as trichomes, host cannabinoids and <a href="https://www.benzinga.com/general/biotech/24/05/38626097/why-does-tangie-smell-so-fruity-because-non-terpene-compounds-include-guava-papaya-and-passionfru">terpenes</a>, and give the flower its quality and potency. These represent the true value in premium cannabis," David noted. 
Read Also: <a href="https://www.benzinga.com/markets/cannabis/23/02/30847170/exclusive-how-to-retail-cannabis-meet-california-brand-gelato-with-a-down-to-earth-approach-for-">EXCLUSIVE: How To Retail Cannabis, Meet California Brand &#8216;Gelato&#8217; With A Down-To-Earth Approach For Organic Growth</a>
<h3 class="wp-block-heading">Tech For Top-Line Revenue&nbsp;</h3>
At the core of Cannatrol's success is its patented approach to controlling temperature and dew point independently, which allows for pinpoint control of vapor pressure. "We're not just controlling humidity," David emphasized. "We're controlling the entire environment, down to the molecular level."
This precise control leads to a significantly better product. Research conducted in partnership with the Cannabis Research Coalition found that flowers dried using Cannatrol's technology retained 17% more <a href="https://www.benzinga.com/general/biotech/23/10/35472080/is-there-untapped-business-potential-beyond-terpenes-in-exotic-cannabis-new-study-sheds-light">terpenes</a> than cannabis dried with conventional methods.&nbsp;
Additionally, damage to the <a href="https://www.benzinga.com/markets/cannabis/23/04/31806591/what-are-cannabis-trichomes-and-whats-their-importance">trichome heads</a>—a key factor in cannabis potency—was reduced to just 1–2%, compared to 25–35% with air conditioners and dehumidifiers​.
David explained: "The trichomes are where all the <a href="https://www.benzinga.com/markets/cannabis/23/12/36394288/cannabis-2024-experts-weigh-in-what-to-expect-from-dc-and-business-outlook-exciting-point-in-tim">valuable cannabinoids</a> and terpenes are stored, so any damage directly affects the product's quality and potency. By preserving more of the trichomes, growers not only improve the overall quality of their cannabis but also protect their top-line revenue."
<h3 class="wp-block-heading">Modular Features&nbsp;</h3>
The technology itself is adaptable, with options ranging from a consumer-grade unit the size of a dorm fridge to large-scale commercial systems capable of handling up to 720 pounds of wet flowers. "Our units are turnkey," said Jane, who leads Cannatrol's marketing efforts. "They're designed for easy setup, whether it's a home grower or a large commercial operation."
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="700" height="525" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/18190046/Old-Growth-Project-Page-Pictures-1.png" alt="" class="wp-image-555104" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/18190046/Old-Growth-Project-Page-Pictures-1.png 700w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/18190046/Old-Growth-Project-Page-Pictures-1-300x225.png 300w" sizes="(max-width: 700px) 100vw, 700px" /><figcaption class="wp-element-caption">Courtesy of Cannatrol</figcaption></figure>
What sets Cannatrol apart is the elimination of manual labor and guesswork. Traditional drying rooms require constant monitoring to prevent over-drying or mold growth, which can lead to product loss and reduced shelf life. Cannatrol's systems remove these risks. "Once the flower is in our system, it doesn't need to be moved or checked," Jane noted. "You don't risk over-drying and the flower is ready to be stored or consumed directly from the unit."
Read Also: <a href="https://www.benzinga.com/markets/cannabis/23/01/30453778/exclusive-presidential-cannabis-californias-blunt-kings-share-their-recipe-to-succeed-in-retail">EXCLUSIVE: Presidential Cannabis — California&#8217;s Blunt Kings Share Their Recipe To Succeed In Retail</a>
<h3 class="wp-block-heading">The Business Advantage: Cutting Costs And Boosting Quality</h3>
David highlighted the financial impact of investing in postharvest processes: "Facilities using conventional methods can lose as much as 5% of their revenue by overdrying their flower and volatilizing terpenes. That's throwing money out the door. We're not just helping growers save money—we're helping them build a brand based on consistent, <a href="https://www.benzinga.com/markets/cannabis/24/09/40886620/how-this-former-dea-consultant-is-making-craft-cannabis-profitable-in-new-jersey-a-dirt-y-little">high-quality flowers</a>."
Moreover, Cannatrol's systems allow growers to maintain shelf stability for a longer time, which is critical for brands looking to differentiate themselves in a crowded market. "We've had clients tell us that our system has led to longer-lasting products on dispensary shelves, which ultimately translates to better consumer satisfaction," Jane added.
<h3 class="wp-block-heading">Entrepreneurial Spirit And Innovation</h3>
At the heart of Cannatrol's success is the Sandelmans&#8217; drive to solve problems with technical innovation. Their journey from Vermont restaurateurs to cannabis industry pioneers is a testament to the power of engineering and invention.&nbsp;
"We didn't set out to revolutionize cannabis drying," David reflected. "We saw a problem, and we came up with a solution. The cannabis industry was just the next frontier."
For the Sandelmans, it's not just about profit margins or flashy new technology: it's about crafting solutions that work. "Our focus has always been on creating the best product possible," Jane said. "If you're solving a problem and making something better, the business success will follow."
With thousands of units sold across 16 countries and growing demand from large-scale commercial operations, the Sandelmans' vision is expanding rapidly—and they're showing no signs of slowing down. 
Read Next: <a href="https://www.benzinga.com/general/biotech/23/08/33579692/cannabis-robots-meet-the-company-boosting-efficiency-and-margins-through-packaging-automation">Cannabis Robots: Meet The Company Boosting Efficiency And Margins Through Packaging Automation</a>

Entrepreneurship

Success Stories

Exclusives

Tech

Interview

How This Cheese-Aging Tech Is Boosting Profits For Cannabis Growers: Stop Throwing Cheddar Out The Door

Litecoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ltc/usd">LTC</a>) price has increased 3.58% over the past 24 hours to $65.12. Over the past week, LTC has experienced an uptick of over 5.0%, moving from $61.93 to its current price. As it stands right now, the coin's all-time high is $410.26. 
The chart below compares the price movement and volatility for Litecoin over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1726758227_0.png" alt="price_chart" />
Litecoin's trading volume has climbed 22.0% over the past week, moving in tandem, directionally, with the overall circulating supply of the coin, which has increased 0.38%. This brings the circulating supply to 74.99 million, which makes up an estimated 89.28% of its max supply of 84.00 million. According to our data, the current market cap ranking for LTC is #25 at $4.88 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1726758227_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$LTC

Cryptocurrency Litecoin Rises More Than 3% In 24 hours

Over the past 24 hours, Aptos's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">APT</a>) price rose 14.46% to $6.61. This continues its positive trend over the past week where it has experienced a 8.0% gain, moving from $6.12 to its current price. As it stands right now, the coin's all-time high is $19.92. 
The chart below compares the price movement and volatility for Aptos over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1726758156_0.png" alt="price_chart" />
The trading volume for the coin has increased 106.0% over the past week while the overall circulating supply of the coin has increased 2.84% to over 500.08 million. The current market cap ranking for APT is #32 at $3.31 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1726758157_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$APT

Cryptocurrency Aptos's Price Increased More Than 14% Within 24 hours

SPIR, ADTH and AWIN among pre-market losers

OncoCyte (OCX) has issued an update. Oncocyte Corporation's Board of Directors, following the Compensation Committee's advice, has agreed to signif...

OncoCyte Executive Team Receives Significant Salary Increases

Oncocyte appoints CFO

OncoCyte (OCX) just unveiled an announcement. Oncocyte Corporation has appointed Andrea James as their new Chief Financial Officer and Principal Fi...

OncoCyte Announces Andrea James as New CFO and Principal Officer

OncoCyte ($OCX), a player in the precision diagnostics market, is helping to usher in a new standard of patient care for chronic conditions like or...

OncoCyte (OCX) Introduces a New Standard in Health Diagnostics

OncoCyte ($OCX), a player in the precision diagnostics market, designed a new diagnostic tool to help treat chronic conditions like organ transplan...

OncoCyte's (OCX) Stock Rises With New Diagnostic Product and Promising Partnership.

OncoCyte GAAP EPS of -$0.36 beats by $0.19, revenue of $0.1M misses by $0.21M

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
OncoCyte (NASDAQ:<a href="https://investorplace.com/stock-quotes/ocx-stock-quote/">OCX</a>) just reported results for the second quarter of 2024.<ul><li>OncoCyte reported earnings per share of -36 cents. This was above the analyst estimate for EPS of -56 cents.</li><li>The company reported revenue of $104,000.</li><li>This was 67.50% worse than the analyst estimate for revenue of $320,000.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/ocx-stock-earnings-oncocyte-for-q2-of-2024/">OCX Stock Earnings: OncoCyte Beats EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

OCX Stock Earnings: OncoCyte Beats EPS, Misses Revenue for Q2 2024

OncoCyte (OCX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Matson from Needham ...

OncoCyte's Growth Potential and Strategic Positioning Bolster Buy Rating

OncoCyte Corporation (OCX) Q2 2024 Earnings Call Transcript

ADTH

AWIN

AXON

DADA

EDBL

EYEN

GLUE

NICE

SPIR

TIRX

Press Releases

Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft Study

OncoCyte's Innovative Approach: Potential in Precision Diagnostics

Management

Oncocyte Appoints Andrea James as Chief Financial Officer

Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Leadership Move

MedTech Gurus Podcast Features Oncocyte CEO Josh Riggs in "Take Advantage of the Moment" Episode

Oncocyte to Announce Second Quarter 2024 Financial Results on August 8

Oncocyte Announces August Investor Conferences Participation

Earnings

Oncocyte Announces Successful GraftAssure™ Beta Launch and Q2 2024 Results

Health Care

Oncocyte's VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study

Biotech

PRISM MarketView Features Oncocyte CFO Andrea S. James on Her Career and Leadership in Molecular Diagnostics Technology

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

OncoCyte

OncoCyte (OCX) Forecast

OncoCyte (NASDAQ:OCX) Stock, Quote.Headers.trade-ideas